LBA40 Neoadjuvant nivolumab and nivolumab plus ipilimumab induce (near-) complete responses in patients with head and neck squamous cell carcinoma: The IMCISION trial

Autor: Zuur, L., Vos, J.L., Elbers, J.B., Krijgsman, O., Qiao, X., van der Leun, A., Smit, L., van den Brekel, M.W., Tan, B., Jasperse, B., Vogel, W.V., Willems, S.M., Al-Mamgani, A., Peeper, D., Schumacher, T.N., Blank, C.U., de Boer, J.P., Haanen, J.B.A.G.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S1169-S1169
Databáze: ScienceDirect